Published in Br Med J (Clin Res Ed) on August 01, 1987
Changing character of cervical cancer in young women. BMJ (1989) 2.66
Age, socio-economic status and survival from cancer of cervix in the West of Scotland 1980-87. Br J Cancer (1993) 2.57
Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases. Br Med J (Clin Res Ed) (1988) 1.73
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer (1997) 1.63
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42
Survival among women with cancer of the uterine cervix: influence of marital status and social class. J Epidemiol Community Health (1990) 1.15
Cervical cancer screening and registration--are they working? J Epidemiol Community Health (1990) 1.13
In vitro platinum drug chemosensitivity of human cervical squamous cell carcinoma cell lines with intrinsic and acquired resistance to cisplatin. Br J Cancer (1993) 0.96
Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis. Br J Cancer (1992) 0.95
The increasing frequency of cervical cancer in Korean women under 35. Cancer Res Treat (2008) 0.93
Problems of follow-up for abnormal cervical smears: discussion paper. J R Soc Med (1990) 0.93
A study of association between expression of hOGG1, VDAC1, HK-2 and cervical carcinoma. J Exp Clin Cancer Res (2010) 0.87
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer (1977) 53.23
Invasive cervical carcinoma in young women. Gynecol Oncol (1979) 1.17
Carcinoma of the cervix in the young patient. Obstet Gynecol (1977) 1.12
The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix. Cancer (1983) 1.01
Radiosensitivity and virulence factors in cervical cancer. Individualization of treatment. Am J Obstet Gynecol (1968) 1.00
Relation of histologic factors to the response of stage I epidermoid carcinoma of the cervix to surgical treatment. Analysis of 115 patients. Obstet Gynecol (1970) 0.99
Evidence for the existence of two forms of cervical carcinoma. J Obstet Gynaecol Br Commonw (1966) 0.96
Combined treatment of stage Ib carcinoma of the cervix. Obstet Gynecol (1973) 0.94
Age and prognosis in stage Ib squamous cell carcinoma of the uterine cervix. Gynecol Oncol (1983) 0.93
Invasive carcinoma of the cervix in young women. J Am Med Assoc (1955) 0.91
Carcinoma of the cervix: the effect of age on survival. Gynecol Oncol (1980) 0.91
Carcinoma of the cervix in young women. I. Invasive carcinoma. Obstet Gynecol (1971) 0.86
Age and 5-year survival rates in patients with operated carcinoma of the cervix. Gynecol Oncol (1982) 0.86
Carcinoma of the uterine cervix; incidence and influence of age; a statistical study. Acta Radiol Suppl (1952) 0.85
SURGICAL AND RADIATION TREATMENT OF CARCINOMA OF THE UTERINE CERVIX. EXPERIENCE BY THE CURRENT INDIVIDUALIZED STOCKHOLM TECHNIQUE. Acta Obstet Gynecol Scand (1964) 0.84
Prognostic and treatment factors affecting pelvic control of Stage IB and IIA-B carcinoma of the intact uterine cervix treated with radiation therapy alone. Cancer (1984) 0.84
Stage I carcinoma of the uterine cervix in patients under 40 years of age. Am J Obstet Gynecol (1976) 0.81
BIOLOGICAL AND PHYSICAL FACTORS IN THE RADIOTHERAPY OF CARCINOMA OF THE CERVIX. J Obstet Gynaecol Br Commonw (1965) 0.81
Cervical cancer; factors influencing prognosis in intraepithelial and clinical carcinoma of the cervix uteri. Obstet Gynecol (1956) 0.81
The impact of lymph node status on survival in cervical carcinoma. Int J Radiat Oncol Biol Phys (1981) 0.80
RESULTS OF THE SURGICAL AND RADIOLOGICAL TREATMENT OF CARCINOMA OF THE CERVIX AT THE WOMEN'S CLINIC, UNIVERSITY OF HELSINKI, IN 1953-1958. Acta Obstet Gynecol Scand (1965) 0.80
Variations in the malignancy of cancers of the uterine cervix. J Obstet Gynaecol Br Emp (1960) 0.80
Carcinoma of the cervix. I. Therapeutic and patient factors affecting survival. Am J Obstet Gynecol (1970) 0.80
BIOLOGICAL FACTORS INFLUENCING THE RADIOTHERAPEUTIC RESULTS IN CARCINOMA OF THE CERVIX. Br J Radiol (1965) 0.79
A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity. J Med Genet (1992) 3.63
A clinical study of type 2 neurofibromatosis. Q J Med (1992) 3.23
Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res (2001) 2.66
Pretreatment prognostic factors and scoring system in 407 small-cell lung cancer patients. Int J Cancer (1987) 2.18
Predicting the onset of smoking in boys and girls. Soc Sci Med (1989) 2.10
Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol (2000) 2.07
Sarcomas in north west England: I. Histopathological peer review. Br J Cancer (1991) 1.95
Improvements in survival from childhood cancer: results of a population based survey over 30 years. Br Med J (Clin Res Ed) (1988) 1.94
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer (1997) 1.63
A genetic study of type 2 neurofibromatosis in the United Kingdom. II. Guidelines for genetic counselling. J Med Genet (1992) 1.62
Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome. Oncogene (1998) 1.59
Cancer in the families of children with soft tissue sarcoma. Cancer (1990) 1.47
Identification of factors associated with high breast cancer risk in the mothers of children with soft tissue sarcoma. J Clin Oncol (1990) 1.45
A radiation-controlled molecular switch for use in gene therapy of cancer. Gene Ther (2000) 1.45
Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br J Cancer (1993) 1.42
Severe Gardner syndrome in families with mutations restricted to a specific region of the APC gene. Am J Hum Genet (1995) 1.37
A monoclonal antibody detects heterogeneity in vascular endothelium of tumours and normal tissues. Int J Cancer (1993) 1.34
Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone. Gut (2004) 1.33
Absence from school related to children's and parental smoking habits. BMJ (1989) 1.32
Radiosensitivity testing of primary cervical carcinoma: evaluation of intra- and inter-tumour heterogeneity. Radiother Oncol (1990) 1.23
Neurofibromatosis in children with soft tissue sarcoma. Pediatr Hematol Oncol (1988) 1.21
Radiotherapy in seminoma of the testis. Clin Radiol (1983) 1.20
Levels of the DNA repair enzyme human apurinic/apyrimidinic endonuclease (APE1, APEX, Ref-1) are associated with the intrinsic radiosensitivity of cervical cancers. Br J Cancer (1998) 1.15
Apoptosis, intrinsic radiosensitivity and prediction of radiotherapy response in cervical carcinoma. Radiother Oncol (1995) 1.14
Space-time clustering patterns in childhood leukaemia support a role for infection. Br J Cancer (2000) 1.14
Evidence that an HLA-DQA1-DQB1 haplotype influences susceptibility to childhood common acute lymphoblastic leukaemia in boys provides further support for an infection-related aetiology. Br J Cancer (1998) 1.14
Frequency of down-regulation of individual HLA-A and -B alleles in cervical carcinomas in relation to TAP-1 expression. Br J Cancer (1995) 1.13
Seasonal variations in the onset of childhood leukaemia and lymphoma. Br J Cancer (1998) 1.12
The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): case control study of children with bone and soft tissue sarcomas. Br J Cancer (1988) 1.09
Sarcomas in north west England: II. Incidence. Br J Cancer (1991) 1.09
Chromoendoscopic surveillance in hereditary diffuse gastric cancer: an alternative to prophylactic gastrectomy? Gut (2005) 1.09
Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix. Br J Cancer (2000) 1.07
Orchidectomy alone for stage I testicular teratoma. Br Med J (Clin Res Ed) (1981) 1.05
CT scanning in intracavitary therapy: unexpected findings in "straightforward" insertions. Radiother Oncol (1988) 1.04
High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res (1998) 1.03
Irradiation induced expression of CD31, ICAM-1 and VCAM-1 in human microvascular endothelial cells. Anticancer Res (2000) 1.03
Changes in oxygenation during radiotherapy in carcinoma of the cervix. Int J Radiat Oncol Biol Phys (1999) 1.03
The Inter-Regional Epidemiological Study of Childhood Cancer (IRESCC): past medical history in children with cancer. J Epidemiol Community Health (1988) 1.02
Clinical outcome for chemoradiotherapy in carcinoma of the cervix. Clin Oncol (R Coll Radiol) (2008) 1.00
Evaluation of surviving fraction at 2 Gy as a potential prognostic factor for the radiotherapy of carcinoma of the cervix. Int J Radiat Biol (1989) 0.99
Cancer in young people in the north of England, 1968-85: analysis by census wards. J Epidemiol Community Health (1993) 0.98
Tumour vascularity is a significant prognostic factor for cervix carcinoma treated with radiotherapy: independence from tumour radiosensitivity. Br J Cancer (1999) 0.94
Lack of association between in vitro clonogenic growth of human cervical carcinoma and tumour stage, differentiation, patient age, host cell infiltration or patient survival. Int J Cancer (1992) 0.94
Pulmonary carcinoid tumours: a clinico-pathological study of 35 cases. Br J Cancer (1986) 0.94
The intrinsic radiosensitivity of normal and tumour cells. Int J Radiat Biol (1998) 0.93
Living kidney donation: recovery and return to activities of daily living. Clin Transplant (2000) 0.92
A correlation between residual DNA double-strand breaks and clonogenic measurements of radiosensitivity in fibroblasts from preradiotherapy cervix cancer patients. Int J Radiat Oncol Biol Phys (1997) 0.92
Lymphocyte radiosensitivity is a significant prognostic factor for morbidity in carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2001) 0.92
Prediction of cervical carcinoma response to radiotherapy. Lancet (1991) 0.91
Hypoparathyroidism and hypocalcaemia occurring during cancer chemotherapy. Br Med J (Clin Res Ed) (1982) 0.91
Morbidity in radiotherapy practice. Clin Oncol (R Coll Radiol) (2000) 0.91
The intrinsic radiosensitivity of cervical carcinoma: correlations with clinical data. Int J Radiat Oncol Biol Phys (1995) 0.89
Use of low-dose rate irradiation to measure the intrinsic radiosensitivity of human T-lymphocytes. Int J Radiat Biol (1993) 0.89
Predictive value of clinical examination, transrectal ultrasound and magnetic resonance imaging prior to radiotherapy in carcinoma of the cervix. Br J Radiol (1998) 0.88
Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur J Immunogenet (1996) 0.88
The epidemiology of infant cancers. Br J Cancer Suppl (1992) 0.87
Incorporating biologic measurements (SF(2), CFE) into a tumor control probability model increases their prognostic significance: a study in cervical carcinoma treated with radiation therapy. Int J Radiat Oncol Biol Phys (2001) 0.87
Dose-incidence curves for tumour control and normal tissue injury, in relation to the response of clonogenic cells. Radiother Oncol (1983) 0.86
The inter-regional epidemiological study of childhood cancer (IRESCC): case-control study of children with central nervous system tumours. Br J Neurosurg (1990) 0.86
Reevaluation of the effectiveness of environmental designs to reduce robbery risk in Florida convenience stores. J Occup Environ Med (1995) 0.86
Effect of adjuvants on the immunosuppressive properties of antilymphocytic globulin. Nature (1970) 0.85
Irradiation induces up-regulation of E9 protein (CD105) in human vascular endothelial cells. Int J Cancer (1995) 0.85
Whole body electron therapy in mycosis fungoides--a successful translational technique achieved by modification of an established linear accelerator. Br J Radiol (1979) 0.85
Multiple primary tumours in a population-based series of patients with histopathologically peer-reviewed sarcomas. Br J Cancer (1993) 0.85
Sarcomas in north west England: III. Survival. Br J Cancer (1992) 0.84
Irradiation induces upregulation of CD31 in human endothelial cells. Arterioscler Thromb Vasc Biol (1999) 0.84
Letter: Normolipemic plane xanthoma and histiocytic lymphoma. Arch Dermatol (1976) 0.84
Radiation-induced micronuclei in human fibroblasts in relation to clonogenic radiosensitivity. Br J Cancer (1998) 0.83
25th Paterson Symposium--is there a future for radiosensitivity testing? Br J Cancer (1991) 0.83
Salvaging locoregional recurrence with radiotherapy after surgery in early cervical cancer. Clin Oncol (R Coll Radiol) (2007) 0.83
Treatment of advanced head and neck cancer using synchronous therapy with methotrexate and irradiation. Clin Radiol (1983) 0.83
Geometry adopted by Manchester radium applicators and Selectron afterloading applicators in intracavitary treatment for carcinoma cervix uteri. Br J Radiol (1987) 0.83
Increasing delays in starting radical radiotherapy treatment--the challenges. Clin Oncol (R Coll Radiol) (2003) 0.83
Role of transforming growth factor beta3 in lymphatic metastasis in breast cancer. Int J Cancer (1998) 0.83
Adrenal cortical tumours: epidemiological and familial aspects. Arch Dis Child (1987) 0.83
Radiological changes in the gastrointestinal and genitourinary tract following radiotherapy for carcinoma of the cervix. Clin Radiol (1990) 0.82
Variation of expression of the gene for type 2 neurofibromatosis: absence of a gender effect on vestibular schwannomas, but confirmation of a preponderance of meningiomas in females. J Laryngol Otol (1995) 0.82
The tolerance of re-irradiation of heavily irradiated human skin. Br J Radiol (1977) 0.81
Expression of the proapoptotic protein Bid is an adverse prognostic factor for radiotherapy outcome in carcinoma of the cervix. Br J Cancer (2005) 0.81
Second primary neoplasms in a population-based series of patients diagnosed with renal tumours in childhood. Med Pediatr Oncol (1994) 0.81
Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy. Br J Cancer (1995) 0.81
Patterns of cancer in the families of children with soft tissue sarcoma. Cancer (1993) 0.81
Radiotherapy alone for patients with operable carcinoma of the lung. Chest (1985) 0.80
Living-unrelated kidney donation: a single-center experience. Clin Transplant (1999) 0.80
Bladder base dosage in patients undergoing intracavitary therapy. Radiother Oncol (1986) 0.80
Lung cancer following Hodgkin's disease: a case-control study. Int J Cancer (1992) 0.80
A retrospective study of bladder morbidity in patients receiving intracavitary brachytherapy as all or part of their treatment for cervix cancer. Br J Radiol (2003) 0.79
Cancer risk in second degree relatives of children with soft tissue sarcoma. Br J Cancer (1991) 0.79
Pretreatment plasma TGF beta 1 levels are prognostic for survival but not morbidity following radiation therapy of carcinoma of the cervix. Int J Radiat Oncol Biol Phys (2000) 0.79
Malignant disease in the mothers of a population-based series of young adults with bone and soft tissue sarcomas. Br J Cancer (1991) 0.79
Hypocalcaemia--an unusual complication of successful chemotherapy for metastatic breast cancer. Clin Oncol (1983) 0.78
A clinical trial of two conceptually different radical radiotherapy treatments in stage III carcinoma of the cervix. Clin Radiol (1986) 0.78
Megavoltage electron beam therapy in the treatment of basal and squamous cell carcinomata of the pinna. Clin Radiol (1982) 0.77
Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA. J Immunol Methods (1994) 0.77
Radiotherapy in the treatment of low-grade astrocytomas. I. A survival analysis. Childs Nerv Syst (1995) 0.77
Prognostic significance of c-erbB-2 protein expression in carcinoma of the cervix treated with radiotherapy. J Cancer Res Clin Oncol (1999) 0.77